Canopy Growth Announces New Chair of the Board of Directors
SMITHS FALLS, ON, Oct. 10, 2019 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is pleased to announce that David Klein has been appointed Chair of its Board of Directors effective immediately.
Mr. Klein currently serves as the Executive Vice President and Chief Financial Officer of Constellation Brands, Inc. He has held numerous executive positions in the finance sector over the past 30 years, with a track record of excellence. Mr. Klein specializes in corporate strategy, all aspects of finance and accounting, investor relations, mergers and acquisitions, and information technology. He has served as a Director on Canopy Growth’s Board since 2018.
Canopy Growth is honored to welcome this exceptional leader as Chair of our Board of Directors.
Mark Zekulin, CEO, Canopy Growth
David’s leadership has been extremely valuable to our Board at this pivotal moment in Canopy Growth’s history, and I am confident that he will continue to add value in his new capacity as Board Chair in the years ahead.
Canopy Growth would like to extend sincere thanks to John Bell for his role as interim Chair over the past few months. Mr. Bell will remain as a Director on the Board and will continue to provide the expertise and sound guidance that has been instrumental in the Company’s success to-date.
I’m excited to serve as Canopy Growth’s new Chair of the Board of Directors. There is no company better positioned to win in the emerging global cannabis market.
David Klein, Chair of the Board of Directors
I look forward to continuing to work with Canopy Growth’s very talented leadership team to position the company for long-term, industry-leading profitable growth.
Here’s to Future Growth (and leadership).
About Canopy Growth Corporation
Canopy Growth (TSX:WEED,NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.
Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 4.7 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.